JP2010006705A5 - - Google Patents

Download PDF

Info

Publication number
JP2010006705A5
JP2010006705A5 JP2008155676A JP2008155676A JP2010006705A5 JP 2010006705 A5 JP2010006705 A5 JP 2010006705A5 JP 2008155676 A JP2008155676 A JP 2008155676A JP 2008155676 A JP2008155676 A JP 2008155676A JP 2010006705 A5 JP2010006705 A5 JP 2010006705A5
Authority
JP
Japan
Prior art keywords
cancer
seq
affinity ligand
her2
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008155676A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010006705A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2008155676A priority Critical patent/JP2010006705A/ja
Priority claimed from JP2008155676A external-priority patent/JP2010006705A/ja
Priority to CA2727941A priority patent/CA2727941A1/en
Priority to US12/997,823 priority patent/US20110158988A1/en
Priority to CN2008801297639A priority patent/CN102099376A/zh
Priority to KR1020107027939A priority patent/KR20110036534A/ko
Priority to PCT/SE2008/000694 priority patent/WO2009151356A1/en
Priority to AU2008357729A priority patent/AU2008357729A1/en
Priority to EP08874636A priority patent/EP2294088A1/en
Priority to KR1020127017264A priority patent/KR20130026418A/ko
Publication of JP2010006705A publication Critical patent/JP2010006705A/ja
Publication of JP2010006705A5 publication Critical patent/JP2010006705A5/ja
Pending legal-status Critical Current

Links

JP2008155676A 2008-06-13 2008-06-13 Ｈｅｒ２サブセット Pending JP2010006705A (ja)

Priority Applications (9)

Application Number Priority Date Filing Date Title
JP2008155676A JP2010006705A (ja) 2008-06-13 2008-06-13 Ｈｅｒ２サブセット
KR1020127017264A KR20130026418A (ko) 2008-06-13 2008-12-12 Ｈｅｒ2 의 세포외 도메인 2 및 3 에 대한 항체
KR1020107027939A KR20110036534A (ko) 2008-06-13 2008-12-12 Ｈｅｒ2 의 세포외 도메인 2 및 3 에 대한 항체
US12/997,823 US20110158988A1 (en) 2008-06-13 2008-12-12 Antibodies against extracellular domains 2 and 3 or her2
CN2008801297639A CN102099376A (zh) 2008-06-13 2008-12-12 针对her2的细胞外结构域2和3的抗体
CA2727941A CA2727941A1 (en) 2008-06-13 2008-12-12 Antibodies against extracellular domains 2 and 3 or her2
PCT/SE2008/000694 WO2009151356A1 (en) 2008-06-13 2008-12-12 Antibodies against extracellular domains 2 and 3 or her2
AU2008357729A AU2008357729A1 (en) 2008-06-13 2008-12-12 Antibodies against extracellular domain 2 and 3 of HER2
EP08874636A EP2294088A1 (en) 2008-06-13 2008-12-12 Antibodies against extracellular domains 2 and 3 or her2

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2008155676A JP2010006705A (ja) 2008-06-13 2008-06-13 Ｈｅｒ２サブセット

Publications (2)

Publication Number Publication Date
JP2010006705A JP2010006705A (ja) 2010-01-14
JP2010006705A5 true JP2010006705A5 (OSRAM) 2011-07-21

Family

ID=40427661

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008155676A Pending JP2010006705A (ja) 2008-06-13 2008-06-13 Ｈｅｒ２サブセット

Country Status (8)

Country Link
US (1) US20110158988A1 (OSRAM)
EP (1) EP2294088A1 (OSRAM)
JP (1) JP2010006705A (OSRAM)
KR (2) KR20110036534A (OSRAM)
CN (1) CN102099376A (OSRAM)
AU (1) AU2008357729A1 (OSRAM)
CA (1) CA2727941A1 (OSRAM)
WO (1) WO2009151356A1 (OSRAM)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101759209B1 (ko) 2010-01-22 2017-07-19 성균관대학교산학협력단 Ｈｅｒ－２ 과발현 유방암 세포 또는 조직에 특이적으로 결합할 수 있는 핵산 압타머 및 그 용도
US8609095B2 (en) 2010-03-04 2013-12-17 Symphogen A/S Anti-HER2 antibodies and compositions
CN103153339B (zh) * 2010-05-27 2021-05-04 根马布股份公司 针对her2表位的单克隆抗体
NZ604003A (en) * 2010-05-27 2015-04-24 Genmab As Monoclonal antibodies against her2
AU2016201799B2 (en) * 2010-05-27 2017-09-07 Genmab A/S Monoclonal antibodies aganst HER2 epitope
AU2012245116A1 (en) 2011-04-20 2013-11-07 Genmab A/S Bispecific antibodies against HER2 and CD3
CN105017425B (zh) * 2014-04-30 2018-02-16 京天成生物技术(北京)有限公司 抗her2中和活性单克隆抗体及其应用
EP3567049A4 (en) 2016-12-28 2020-08-26 Green Cross Lab Cell Corporation CHEMERICAL ANTIGENIC RECEPTOR AND NATURAL KILLER CELLS EXPRESSING THE SAME
US12116417B2 (en) 2017-11-14 2024-10-15 GC Cell Corporation Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen receptor comprising same
US11649294B2 (en) 2017-11-14 2023-05-16 GC Cell Corporation Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen receptor comprising same
US20210346484A1 (en) * 2017-12-11 2021-11-11 Medizinische Universitaet Wien Method of producing a vaccine composition and uses thereof
SG11202100699WA (en) 2018-08-16 2021-02-25 Emd Millipore Corp Closed bioprocessing device
EP3842460A1 (en) * 2019-03-01 2021-06-30 RemeGen Co., Ltd. Antibody for her2 concomitant diagnosis immunohistochemical detection and application thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5801005A (en) * 1993-03-17 1998-09-01 University Of Washington Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated
US6514942B1 (en) * 1995-03-14 2003-02-04 The Board Of Regents, The University Of Texas System Methods and compositions for stimulating T-lymphocytes
US5783404A (en) * 1995-04-13 1998-07-21 Amgen Inc. Methods and compositions for determining HER-2/neu expression using monoclonal antibodies
JP2003530083A (ja) * 1999-12-10 2003-10-14 エピミューン インコーポレイテッド ペプチドおよび核酸組成物を使用する、ＨＥＲ２／ｎｅｕに対する細胞性免疫応答の誘導
JP2005500034A (ja) * 2001-06-20 2005-01-06 プロション バイオテク リミテッド 受容体型タンパク質チロシンキナーゼ活性化を遮断する抗体、そのスクリーニング方法、及びその使用
CN1136917C (zh) * 2001-10-10 2004-02-04 北京迪威华宇生物技术有限公司 一种卡介苗热休克蛋白65和多表位her-2抗原融合蛋白重组蛋白疫苗
EP1583548A4 (en) * 2002-12-10 2007-10-17 Epimmune Inc HLA-A1, A2 -A3, -A24, -B7 AND B44TUMOR ASSOCIATED ANTIGENPEPTIDES AND COMPOSITIONS
US7767792B2 (en) * 2004-02-20 2010-08-03 Ludwig Institute For Cancer Research Ltd. Antibodies to EGF receptor epitope peptides
GT200500155A (es) * 2004-06-16 2006-05-15 Terapia del càncer resistente al platino
KR20190126461A (ko) * 2004-07-22 2019-11-11 제넨테크, 인크. Ｈｅｒ２ 항체 조성물
EP1844788B1 (en) * 2006-04-13 2010-07-14 Bio Life Science Forschungs- und Entwicklungsges.m.b.H. HER-2/neu multi-peptide vaccine
SG172692A1 (en) * 2006-06-12 2011-07-28 Symphogen As Pan-cell surface receptor- specific therapeutics
CN101165068B (zh) * 2006-10-18 2011-09-21 上海复旦张江生物医药股份有限公司 抗HER2/ErbB2抗原的单克隆抗体及其制备方法和药物组合物

Similar Documents

Publication Publication Date Title
JP2010006705A5 (OSRAM)
JP2012100677A5 (OSRAM)
Villa et al. A high‐affinity human monoclonal antibody specific to the alternatively spliced EDA domain of fibronectin efficiently targets tumor neo‐vasculature in vivo
JP2014518615A5 (OSRAM)
ES2742287T3 (es) Anticuerpos monoclonales contra el factor de diferenciación de crecimiento 15 (GDF-15)
JP2009505676A5 (OSRAM)
JP2012523848A5 (OSRAM)
JP2014088414A5 (OSRAM)
HRP20192347T1 (hr) Antitijela prema klaudinu 18.2 koja su korisna u dijagnozi tumora
JP2010533498A5 (OSRAM)
CN106604932B (zh) 人白细胞介素-2的免疫刺激单克隆抗体
JP2007536932A5 (OSRAM)
SI2342234T1 (en) MONOCOLIC ANTI-GT468 CANCER CANCER PROTITEL
JP2010163438A5 (OSRAM)
CA2595610A1 (en) Antibodies directed to angiopoietin-2 and uses thereof
JP2018530331A5 (OSRAM)
HRP20230078T1 (hr) Sredstva za vezivanje vegf/dll4 i njihova uporaba
JP2014534806A5 (OSRAM)
JP2010111679A5 (OSRAM)
JP2013527761A5 (OSRAM)
JP2005225884A5 (OSRAM)
JP2015525208A5 (OSRAM)
JP2015529641A5 (OSRAM)
JP2007532139A5 (OSRAM)
JP2016536330A5 (OSRAM)